tiprankstipranks
Pacira Pharmaceuticals (PCRX)
NASDAQ:PCRX
PCRX
Pacira Pharmaceuticals
RESEARCH TOOLSreports
Want to see PCRX full AI Analyst Report?

Pacira Pharmaceuticals (PCRX) Revenue

384 Followers
StatisticsMarket CapRevenue

Pacira Pharmaceuticals Revenue

Pacira Pharmaceuticals had a revenue of 177.38M in the quarter ending Mar 31, 2026, with -9.90%. This bring the company's revenue in the last twelve months to 734.86M, Decreased 1.16%. In the fiscal year ending Dec 31, 2025, Pacira Pharmaceuticals had annual revenue of 726.41M with 3.63% growth.
Revenue (ttm)
734.86M
Revenue Growth
3.63%
P/S Ratio
1.38
Revenue/Employee
$921,841
Employees
788
Market Cap
$1.00B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
726.41M25.45M+3.63%
Dec 31, 2024
700.97M25.99M+3.85%
Dec 31, 2023
674.98M8.15M+1.22%
Dec 31, 2022
666.82M125.29M+23.14%
Dec 31, 2021
541.53M111.89M+26.04%
Dec 31, 2020
429.65M8.62M+2.05%
Dec 31, 2019
421.03M83.75M+24.83%
Dec 31, 2018
337.28M50.65M+17.67%
Dec 31, 2017
286.63M――